Yu Xiao

Yu Xiao

Auto-generated profile, based on publicly available information

Yu Xiao

Department of Chemistry, The University of Chicago, Chicago, USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2024 in Science Advances
Verified
Journal Article
Open access
JWJinjun Wu
Jinjun Wu
YXYu Xiao
Yu Xiao
YLYunzheng Liu
Yunzheng Liu
LWLi Wen
Li Wen
CJChuanyang Jin
Chuanyang Jin
JFJingyi Fei
Jingyi Fei
Nuclear speckles are nuclear membraneless organelles in higher eukaryotic cells playing a vital role in gene expression. Using an in situ reverse transcription–based sequencing method, we study nuclear speckle–associated human transcripts. Our data indicate the existence of three gene groups whose transcripts demonstrate different speckle localization properties: stably enriched in nuclear speckles, transiently enriched in speckles at the pre–messenger RNA stage, and not enriched. We find that stably enriched transcripts contain inefficiently excised introns and that disruption of nuclear speckles specifically affects splicing of speckle-enriched transcripts. We further reveal RNA sequence features contributing to transcript speckle localization, indicating a tight interplay between transcript speckle enrichment, genome organization, and splicing efficiency. Collectively, our data highlight a role of nuclear speckles in both co- and posttranscriptional splicing regulation. Last, we show that genes with stably enriched transcripts are over-represented among genes with heat shock–up-regulated intron retention, hinting at a connection between speckle localization and cellular stress response.

10 January 2024 in Nature Methods
Verified
Journal Article
Open access
PDF file
YXYu Xiao
Yu Xiao
YCYan-Ming Chen
Yan-Ming Chen
ZZZhongyu Zou
Zhongyu Zou
CYChang Ye
Chang Ye
XDXiaoyang Dou
Xiaoyang Dou
CHChuan He
Chuan He
RNA-binding proteins (RBPs) regulate diverse cellular processes by dynamically interacting with RNA targets. However, effective methods to capture both stable and transient interactions between RBPs and their RNA targets are still lacking, especially when the interaction is dynamic or samples are limited. Here we present an assay of reverse transcription-based RBP binding site sequencing (ARTR-seq), which relies on in situ reverse transcription of RBP-bound RNAs guided by antibodies to identify RBP binding sites. ARTR-seq avoids ultraviolet crosslinking and immunoprecipitation, allowing for efficient and specific identification of RBP binding sites from as few as 20 cells or a tissue section. Taking advantage of rapid formaldehyde fixation, ARTR-seq enables capturing the dynamic RNA binding by RBPs over a short period of time, as demonstrated by the profiling of dynamic RNA binding of G3BP1 during stress granule assembly on a timescale as short as 10 minutes.

9 June 2026 in Nature Methods
Verified
Journal Article
Closed access
PDF file
YXYu Xiao
Yu Xiao
ZBZhiliang Bai
Zhiliang Bai
ZZZhuoning Zou
Zhuoning Zou
CYChang Ye
Chang Ye
BTBo Tao
Bo Tao
CHChuan He
Chuan He

15 June 2025 in bioRxiv
Verified
Preprint
Open access
YYYingzhi Ye
Yingzhi Ye
ZZZhe Zhang
Zhe Zhang
YXYu Xiao
Yu Xiao
CZChengzhang Zhu
Chengzhang Zhu
NWNoelle Wright
Noelle Wright
SSShuying Sun
Shuying Sun
SUMMARY: The proteinopathy of the RNA-binding protein TDP-43, characterized by nuclear clearance and cytoplasmic inclusion, is a hallmark of multiple neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and Alzheimer’s disease (AD). Through CRISPR interference (CRISPRi) screening in human neurons, we identified the decapping enzyme scavenger (DCPS) as a novel genetic modifier of TDP-43 loss-of-function (LOF)-mediated neurotoxicity. Our findings reveal that TDP-43 LOF leads to aberrant mRNA degradation, via disrupting the properties and function of processing bodies (P-bodies). TDP-43 interacts with P-body component proteins, potentially influencing their dynamic equilibrium and assembly into ribonucleoprotein (RNP) granules. Reducing DCPS restores P-body integrity and RNA turnover, ultimately improving neuronal survival. Overall, this study highlights a novel role of TDP-43 in RNA processing through P-body regulation and identifies DCPS as a potential therapeutic target for TDP-43 proteinopathy-related neurodegenerative diseases.

31 August 2026 in ACS Chemical Biology
Verified
Journal Article
Closed access
KXKun Xu
Kun Xu
XHXiang Huan
Xiang Huan
YXYu Xiao
Yu Xiao